Daratumumab Injection Market, Global Outlook and Forecast 2022-2028

April 2022 | 62 pages | ID: D11A449B864DEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Daratumumab Injection in Global, including the following market information:

Global Daratumumab Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Daratumumab Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

100 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Daratumumab Injection include Johnson & Johnson, Xi'an Janssen Pharmaceutical and Shanghai Henlius Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Daratumumab Injection companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Daratumumab Injection Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Daratumumab Injection Market Segment Percentages, by Type, 2021 (%)

• 100 mg
• 400 mg

Global Daratumumab Injection Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Daratumumab Injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Daratumumab Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Daratumumab Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Daratumumab Injection revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Daratumumab Injection revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Johnson & Johnson
• Xi'an Janssen Pharmaceutical
• Shanghai Henlius Biotech

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Daratumumab Injection Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Daratumumab Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DARATUMUMAB INJECTION OVERALL MARKET SIZE

2.1 Global Daratumumab Injection Market Size: 2021 VS 2028
2.2 Global Daratumumab Injection Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Daratumumab Injection Players in Global Market
3.2 Top Global Daratumumab Injection Companies Ranked by Revenue
3.3 Global Daratumumab Injection Revenue by Companies
3.4 Top 3 and Top 5 Daratumumab Injection Companies in Global Market, by Revenue in 2021
3.5 Global Companies Daratumumab Injection Product Type
3.6 Tier 1, Tier 2 and Tier 3 Daratumumab Injection Players in Global Market
  3.6.1 List of Global Tier 1 Daratumumab Injection Companies
  3.6.2 List of Global Tier 2 and Tier 3 Daratumumab Injection Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Daratumumab Injection Market Size Markets, 2021 & 2028
  4.1.2 100 mg
  4.1.3 400 mg
4.2 By Type - Global Daratumumab Injection Revenue & Forecasts
  4.2.1 By Type - Global Daratumumab Injection Revenue, 2017-2022
  4.2.2 By Type - Global Daratumumab Injection Revenue, 2023-2028
  4.2.3 By Type - Global Daratumumab Injection Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Daratumumab Injection Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Daratumumab Injection Revenue & Forecasts
  5.2.1 By Application - Global Daratumumab Injection Revenue, 2017-2022
  5.2.2 By Application - Global Daratumumab Injection Revenue, 2023-2028
  5.2.3 By Application - Global Daratumumab Injection Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Daratumumab Injection Market Size, 2021 & 2028
6.2 By Region - Global Daratumumab Injection Revenue & Forecasts
  6.2.1 By Region - Global Daratumumab Injection Revenue, 2017-2022
  6.2.2 By Region - Global Daratumumab Injection Revenue, 2023-2028
  6.2.3 By Region - Global Daratumumab Injection Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Daratumumab Injection Revenue, 2017-2028
  6.3.2 US Daratumumab Injection Market Size, 2017-2028
  6.3.3 Canada Daratumumab Injection Market Size, 2017-2028
  6.3.4 Mexico Daratumumab Injection Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Daratumumab Injection Revenue, 2017-2028
  6.4.2 Germany Daratumumab Injection Market Size, 2017-2028
  6.4.3 France Daratumumab Injection Market Size, 2017-2028
  6.4.4 U.K. Daratumumab Injection Market Size, 2017-2028
  6.4.5 Italy Daratumumab Injection Market Size, 2017-2028
  6.4.6 Russia Daratumumab Injection Market Size, 2017-2028
  6.4.7 Nordic Countries Daratumumab Injection Market Size, 2017-2028
  6.4.8 Benelux Daratumumab Injection Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Daratumumab Injection Revenue, 2017-2028
  6.5.2 China Daratumumab Injection Market Size, 2017-2028
  6.5.3 Japan Daratumumab Injection Market Size, 2017-2028
  6.5.4 South Korea Daratumumab Injection Market Size, 2017-2028
  6.5.5 Southeast Asia Daratumumab Injection Market Size, 2017-2028
  6.5.6 India Daratumumab Injection Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Daratumumab Injection Revenue, 2017-2028
  6.6.2 Brazil Daratumumab Injection Market Size, 2017-2028
  6.6.3 Argentina Daratumumab Injection Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Daratumumab Injection Revenue, 2017-2028
  6.7.2 Turkey Daratumumab Injection Market Size, 2017-2028
  6.7.3 Israel Daratumumab Injection Market Size, 2017-2028
  6.7.4 Saudi Arabia Daratumumab Injection Market Size, 2017-2028
  6.7.5 UAE Daratumumab Injection Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Johnson & Johnson
  7.1.1 Johnson & Johnson Corporate Summary
  7.1.2 Johnson & Johnson Business Overview
  7.1.3 Johnson & Johnson Daratumumab Injection Major Product Offerings
  7.1.4 Johnson & Johnson Daratumumab Injection Revenue in Global Market (2017-2022)
  7.1.5 Johnson & Johnson Key News
7.2 Xi'an Janssen Pharmaceutical
  7.2.1 Xi'an Janssen Pharmaceutical Corporate Summary
  7.2.2 Xi'an Janssen Pharmaceutical Business Overview
  7.2.3 Xi'an Janssen Pharmaceutical Daratumumab Injection Major Product Offerings
  7.2.4 Xi'an Janssen Pharmaceutical Daratumumab Injection Revenue in Global Market (2017-2022)
  7.2.5 Xi'an Janssen Pharmaceutical Key News
7.3 Shanghai Henlius Biotech
  7.3.1 Shanghai Henlius Biotech Corporate Summary
  7.3.2 Shanghai Henlius Biotech Business Overview
  7.3.3 Shanghai Henlius Biotech Daratumumab Injection Major Product Offerings
  7.3.4 Shanghai Henlius Biotech Daratumumab Injection Revenue in Global Market (2017-2022)
  7.3.5 Shanghai Henlius Biotech Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Daratumumab Injection Market Opportunities & Trends in Global Market
Table 2. Daratumumab Injection Market Drivers in Global Market
Table 3. Daratumumab Injection Market Restraints in Global Market
Table 4. Key Players of Daratumumab Injection in Global Market
Table 5. Top Daratumumab Injection Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Daratumumab Injection Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Daratumumab Injection Revenue Share by Companies, 2017-2022
Table 8. Global Companies Daratumumab Injection Product Type
Table 9. List of Global Tier 1 Daratumumab Injection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Daratumumab Injection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Daratumumab Injection Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Daratumumab Injection Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Daratumumab Injection Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Daratumumab Injection Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Daratumumab Injection Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Daratumumab Injection Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Daratumumab Injection Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Daratumumab Injection Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Daratumumab Injection Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Daratumumab Injection Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Daratumumab Injection Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Daratumumab Injection Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Daratumumab Injection Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Daratumumab Injection Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Daratumumab Injection Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Daratumumab Injection Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Daratumumab Injection Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Daratumumab Injection Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Daratumumab Injection Revenue, (US$, Mn), 2023-2028
Table 30. Johnson & Johnson Corporate Summary
Table 31. Johnson & Johnson Daratumumab Injection Product Offerings
Table 32. Johnson & Johnson Daratumumab Injection Revenue (US$, Mn), (2017-2022)
Table 33. Xi'an Janssen Pharmaceutical Corporate Summary
Table 34. Xi'an Janssen Pharmaceutical Daratumumab Injection Product Offerings
Table 35. Xi'an Janssen Pharmaceutical Daratumumab Injection Revenue (US$, Mn), (2017-2022)
Table 36. Shanghai Henlius Biotech Corporate Summary
Table 37. Shanghai Henlius Biotech Daratumumab Injection Product Offerings
Table 38. Shanghai Henlius Biotech Daratumumab Injection Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Daratumumab Injection Segment by Type in 2021
Figure 2. Daratumumab Injection Segment by Application in 2021
Figure 3. Global Daratumumab Injection Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Daratumumab Injection Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Daratumumab Injection Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Daratumumab Injection Revenue in 2021
Figure 8. By Type - Global Daratumumab Injection Revenue Market Share, 2017-2028
Figure 9. By Application - Global Daratumumab Injection Revenue Market Share, 2017-2028
Figure 10. By Region - Global Daratumumab Injection Revenue Market Share, 2017-2028
Figure 11. By Country - North America Daratumumab Injection Revenue Market Share, 2017-2028
Figure 12. US Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Daratumumab Injection Revenue Market Share, 2017-2028
Figure 16. Germany Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 17. France Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Daratumumab Injection Revenue Market Share, 2017-2028
Figure 24. China Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 28. India Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Daratumumab Injection Revenue Market Share, 2017-2028
Figure 30. Brazil Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Daratumumab Injection Revenue Market Share, 2017-2028
Figure 33. Turkey Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Daratumumab Injection Revenue, (US$, Mn), 2017-2028
Figure 37. Johnson & Johnson Daratumumab Injection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Xi'an Janssen Pharmaceutical Daratumumab Injection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Shanghai Henlius Biotech Daratumumab Injection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)